Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
simvastatin
i
Other names:
L-644128-000U, MK-733
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Generic mfg.
Drug class:
HMG-CoA reductase inhibitor
Related drugs:
‹
amlodipine/atorvastatin (1)
atorvastatin (1)
ezetimibe/simvastatin (1)
lovastatin (0)
pitavastatin (0)
amlodipine/atorvastatin (1)
atorvastatin (1)
ezetimibe/simvastatin (1)
lovastatin (0)
pitavastatin (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Breast Cancer
simvastatin
Sensitive: C3 – Early Trials
simvastatin
Sensitive
:
C3
simvastatin
Sensitive: C3 – Early Trials
simvastatin
Sensitive
:
C3
TP53 mutation
Breast Cancer
TP53 mutation
Breast Cancer
docetaxel + simvastatin
Sensitive: D – Preclinical
docetaxel + simvastatin
Sensitive
:
D
docetaxel + simvastatin
Sensitive: D – Preclinical
docetaxel + simvastatin
Sensitive
:
D
TP53 mutation
Breast Cancer
TP53 mutation
Breast Cancer
doxorubicin hydrochloride + simvastatin
Sensitive: D – Preclinical
doxorubicin hydrochloride + simvastatin
Sensitive
:
D
doxorubicin hydrochloride + simvastatin
Sensitive: D – Preclinical
doxorubicin hydrochloride + simvastatin
Sensitive
:
D
TP53 mutation
Breast Cancer
TP53 mutation
Breast Cancer
simvastatin
Sensitive: D – Preclinical
simvastatin
Sensitive
:
D
simvastatin
Sensitive: D – Preclinical
simvastatin
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login